Abstract:Kunjie Zheng, 1– 3 Xiaolong Li, 1– 3 Yihua Rong, 2 Xuejing Wang, 4 Liping Hou, 2 Wei Gu, 2 Xiaoyu Hou, 3 Yunpeng Guan, 5 Lifang Liu, 6 Jianlin Geng, 2 Guangyao Song 1, 3 1 Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 2 Department of Endocrinology, Hengshui People's Hospital, Hengshui, Hebei, People's Republic of China; 3 Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China; 4 Hengshui People's Hospital Statistical Office, Hengshui, Hebei, People's Republic of China; 5 Department of Endocrinology, Shijiazhuang People's Hospital, Shijiazhuang, Hebei Province, People's Republic of China; 6 Department of Endocrinology, Baoding First Central Hospital, Baoding, Hebei, People's Republic of China Correspondence: Guangyao Song, Department of Endocrinology, Hebei General Hospital, 348 Heping West Road, Shijiazhuang, Hebei, 050051, People's Republic of China, Email Purpose: Elevated serum gamma-glutamyltranspeptidase (GGT) is an independent marker of the activation of systemic inflammation, while conditions associated with elevated triglyceride (TG) levels, such as type 2 diabetes, non-alcoholic fatty liver disease, obesity, and metabolic syndrome, are associated with an increased inflammatory burden. Moreover, serum liver enzymes (GGT, alanine aminotransferase [ALT], aspartate aminotransferase [AST], and alkaline phosphatase [ALP]) are associated with metabolic syndrome and its components, including hypertriglyceridemia. However, the relationship between liver enzymes and postprandial hypertriglyceridemia (PHTG) remains unclear. Therefore, in this study we conducted oral fat tolerance tests (OFTTs) to understand the differences in serum liver enzyme levels among individuals with different lipid tolerance levels and their correlation with PHTG. Patients and Methods: For the OFTT, we enrolled 202 non-diabetic volunteers whose fasting triglyceride (TG) levels were less than 1.7 mmol/L in this case-control study. The participants were categorized into two groups according to the TG levels at the 0- and 4-h OFTT: a postprandial normal TG (PNTG) group and a PHTG group. Routine fasting serum biochemical indices, liver enzyme (GGT, ALT, AST, and ALP) levels, and 0- and 4-h OFTT lipid levels were assessed. Results: The PHTG group had significantly higher serum GGT and ALT levels and a lower AST/ALT ratio than those in the PNTG group. However, no significant difference was observed in AST and ALP levels compared with the PNTG group. After adjusting for major confounders, logistic regression analysis indicated a significant correlation between serum GGT and PHTG (odds ratio = 1.168, P < 0.001), but not with ALT level, AST level, AST/ALT ratio, and ALP level. The receiver operating characteristic curve analysis demonstrated that the serum GGT level was an effective predictor of PHTG. Conclusion: Serum GGT levels are significantly associated with PHTG risk and serve as an effective biomarker for early identification. Keywords: gamma-glutamyl transferase, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, inflammation, triglyceride, oral fat tolerance test With rapid economic development and lifestyle changes, the prevalence of hypertriglyceridemia (HTG) in our country has gradually increased. Dyslipidemia poses a serious threat to human health. Elevated levels of triglyceride (TG)-rich lipoprotein cholesterol have been linked to an increased risk of cardiovascular disease, according to large clinical trials. 1,2 In individuals with HTG, fibrate therapy may drastically reduce the incidence of heart attack and death. 3,4 Postprandial hypertriglyceridemia (PHTG) has emerged as a risk factor for atherosclerotic cardiovascular disease (ASCVD). 5–7 Non-fasting lipid profiles are convenient for predicting ASCVD risk and comparable to or even more meaningful than fasting samples. 8,9 Of note, most people only fast for a few hours daily (in the early morning). The postprandial retention of TG-rich residual lipoproteins in the arterial walls may result in the development of atherosclerosis and ASCVD. 6 Therefore, early detection of abnormal PHTG significantly reduces ASCVD occurrence. Serum gamma-glutamyl transferase (GGT) has recently garnered extensive attention because of its role in cardiovascular and metabolic diseases. 10,11 GGT, a glycoprotein present on the surface of the cell membrane, is widely distributed in various organs and cells. It is an enzyme that determines glut -Abstract Truncated-

Serum Gamma Glutamyltransferase: A Biomarker for Identifying Postprandial Hypertriglyceridemia

A cross-sectional study of the relationship between serum liver enzymes level and the incidence of impaired fasting glucose in males and females.

[Plasma Gamma-Glutamyl Transpeptidase Level As a Cardiovascular Risk Factor in Elderly Patients with Hypertension or Hypertension with Diabetes Mellitus].

Gamma-glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction-associated steatotic liver disease

Serum Gamma-Glutamyltransferase is Associated with Impaired Fasting Glucose in Chinese Adults: the Cardiometabolic Risk in Chinese (crc) Study

Association between serum gamma-glutamyltransferase and impaired fasting glucose

Prevalence and Determinants of Elevated Gamma-Glutamyl Transferase in Chinese Hypertensive Adults

Gamma‐glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community‐based cross‐sectional study

Moderate Serum Γ-Glutamyl Transferase Level is Beneficial for Heart Failure after Percutaneous Coronary Intervention.

Gamma-Glutamyltransferase and Risk of Acute Coronary Syndrome in Young Chinese Patients: A Case-Control Study.

Clinical value of γ-glutamyl transpeptidase to platelet ratio and triglyceride measurement in the diagnosis of nonalcoholic fatty liver disease: A cross-sectional study

Circulating gamma‐glutamyl transpeptidase and risk of pancreatic cancer: A prospective cohort study in the UK Biobank

The application of the serum total GGT activity in detection of the severity of coronary heart disease

Serum Alanine Aminotransferase Independently Correlates with Intrahepatic Triglyceride Contents in Obese Subjects

Elevated Serum Gamma-Glutamyltransferase Predicts The Development Of Impaired Glucose Metabolism In Middle-Aged And Elderly Chinese

Identification of the Chinese Population That Can Benefit Most From Postprandial Lipid Testing: Validation of the Use of Oral Fat Tolerance Testing in Clinical Practice

Association of Serum Gamma-Glutamyl Transferase with Treatment Outcome in Chronic Hepatitis B Patients

Elevated serum γ-glutamyltransferase predicts the development of impaired glucose metabolism in middle-aged and elderly Chinese

ADWANCES IN THE STUDY OF CORRELATION BETWEEN SERUM γ-GLUTAMYL TRANSFERASE AND ATHEROSCLEROSIS

Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus

Clinical Significance of Serum Triglyceride Elevation at Early Stage of Acute Biliary Pancreatitis